mesothelioma research

New Discovery: How and Why BAP1 Mutation Increases Susceptibility to Environmental Carcinogens

Michele Carbone, MD, PhD, Director of Thoracic Oncology at the University of Hawaii (UH) Cancer Center, along with his team, have discovered why people carrying mutations of the BAP1 gene are more susceptible to environmental carcinogens, including asbestos, radiation, and ultraviolet light.
BAP1 mutations are seen in approximately 20 percent of all cancers, and Dr. Carbone […]


Updates in Mesothelioma Research from ASCO 2017

The American Society of Clinical Oncology (ASCO) held its Annual Meeting on June 2-6, 2017 in Chicago. The Meso Foundation’s CEO, Melinda Kotzian, and Director of Research and Medical Outreach, Gleneara Bates, MS, MSW, PhD (c), had the opportunity to attend the conference and hear the latest news reported in mesothelioma research.
Hedy Lee Kindler, MD, […]


Results Show Encouraging Survival Data: Nintedanib for Mesothelioma

On June 5, Anna Nowak, MD, PhD, of the University of Western Australia and member of the Meso Foundation’s Science Advisory Board, presented phase II results from LUME-Meso, a mesothelioma clinical trial sponsored by Boehringer Ingelheim, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
LUME-Meso is a randomized, double-blind, placebo-controlled trial evaluating […]


Disparities and Low Participation in Clinical Trials

by Jadmin Mostel, Patient Support and Research Assistant, Mesothelioma Applied Research Foundation
This past March, I attended the National Comprehensive Cancer Network (NCCN) annual conference, and observed a dynamic roundtable discussion about disparities in the medical field. As the conversation was first colored with various factors such as socioeconomic background and language barriers, the conversation took […]


Omnibus Bill Passes, Funds Available to Mesothelioma Research Increase

With the passage of the Omnibus budget bill last week, mesothelioma research will now be eligible for $60 million, an increase of $10 million over the amount previously available.
This particular funding is available through the Department of Defense’s Peer-Reviewed Cancer Research Program (PRCRP), a pot of funding available annually to researchers studying any one of […]